Novità nel mondo di Medicina di Laboratorio

Omega-3 fish oil supplements can improve attention in children with attention deficit hyperactivity disorder (ADHD) just as much as drug treatments, but only in those whose blood levels of omega-3 are low, trial results showed on Wednesday.
Reuters Health Information

The U.S. Food and Drug Administration said on Wednesday it had approved Alnylam Pharmaceuticals Inc's gene silencing drug as a treatment for patients with a rare inherited disorder.
FDA Approvals

Results of Treat Stroke to Target (TST), a rare cholesterol study in patients with a history of ischemic stroke, explore the benefits of treating to a lower LDL target.
Medscape Medical News

In a recent analysis, 1 in 2 'public commenters' giving input on state-level drug coverage decisions was someone with financial ties to the pharmaceutical industry.
Medscape Oncology

Absence of type 1 diabetes-associated autoantibodies and A1c less than 7.5%, along with parental diabetes history, should trigger testing for maturity-onset diabetes of the young.
Medscape Medical News

Internet-distributed HIV self-tests increase testing rates and newly identified infections among men who have sex with men (MSM), according to results from a randomized clinical trial.
Reuters Health Information

Pneumonia is common in patients on a ventilator after cardiac arrest. Results of the ANTHARTIC trial suggest prophylactic antibiotics can reduce that risk.
Medscape Medical News

Skipping lectures. Diagnosing via Twitter. Today's medical trainees eschew traditional teaching techniques for 'higher-yield' approaches.
Medscape Oncology

Kidney transplants between monozygotic twins can be done successfully without immunosuppression, with excellent outcomes, shows an analysis of twin transplants in the modern era.
Medscape Medical News

Immune-related adverse events involving the liver may occur with checkpoint inhibitors. Is routine monitoring of AST, ALT and bilirubin recommended?
Alimentary Pharmacology & Therapeutics

Following in the footsteps of inclisiran, two lipid-lowering therapies based on silencing specific genes involved in lipid metabolism showed promising preliminary results in initial clinical trials.
Medscape Medical News

The FDA continues to get reports of device failures associated with the now-recalled Cardiosave Hybrid, Cardiosave Rescue, CS300, and CS100/CS100i intra-aortic balloon pumps.
News Alerts

How prepared are you to respond to hazardous material situations? Dr Hilton interviewed Eric Pohl, who offers tips on safety to medical personnel.
Medscape Emergency Medicine

Nonbullous pemphigoid can be more frequent among nursing home residents than bullous pemphigoid and may be an unrecognized cause of pruritus, a cross-sectional study suggests.
Reuters Health Information

Interim data suggest slowed plaque progression, in part, may be behind the benefits observed with icosapent ethyl in patients with elevated triglycerides.
Medscape Medical News

Turner syndrome can commonly result in ovarian insufficiency in females, which can impact reproductive function. What strategies may help preserve fertility in these patients?
Clinical Endocrinology

A third phase 3 trial with the novel lipid-lowering drug, given just once every 6 months, has shown impressive LDL lowering for patients with familial hypercholesterolemia (FH).
Medscape Medical News

Better pain management is needed to reduce prescribed opioids, said the scientific lead of the CDC arthritis program, who believes pain is a public health issue.
Medscape Medical News

The National Toxicology Program found a link between high fluoride exposure in children and cognitive impairment, according to a draft report and systematic review.
Medscape Medical News

Although colchicine did not significantly reduce major adverse cardiovascular events after PCI, the researchers are encouraged by significant decreases in markers of inflammation vs placebo.
Medscape Medical News